logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: Drugs
Load new posts () and activity
Like Reblog Comment
text 2020-09-04 14:34
Intravenous Iron Drugs Market Will Rise As Of Growing Cases Of Chronic Kidney Diseases

The global intravenous (IV) iron drugs market size is expected to reach USD 2.90 billion by 2026, expanding at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research. Growing prevalence of chronic diseases, noncompliance of oral drug treatment and recent approvals of novel products are the key factors driving the IV iron drugs market. However, some of the factors that are restraining the market include the adverse side effects, stringent regulations, availability of nutraceutical alternatives, and complex approval process.

 

Iron is one of the crucial components in the hemoglobin and plays an important role in the transportation of oxygen throughout the body. It also takes part in several biological processes such as energy metabolism, formation of collagen, the synthesis of heme, formation of myoglobin, immune system functions, and neurotransmitter production. Around 30% of anemia in women and children in developing nations is caused by deficiency of iron according to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017. Growing cases of chronic kidney diseases, iron deficiency anemia in gastroenterology, gynecology and oncology and growing cohort with high rate of unresponsive oral therapy is expected to drive the demand for these drugs. Furthermore, increasing healthcare expenditure and high accuracy, sensitivity and easy access of intravenous iron drugs fuels the market growth.

 

Request a Free Sample Copy of Intravenous Iron Drugs Market Report @ https://www.radiantinsights.com/research/intravenous-iron-drugs-market/request-sample

 

Among the products, the ferric carboxymaltose segment dominated the global intravenous iron drugs market in 2018 and is expected to grow significantly due to its increasing application in drug discovery processes, superior performance, and reduced cost. Ferric carboxymaltose is marketed as Injectafer in North America and under the name of Ferinject outside North America. Asia Pacific is projected to demonstrate the highest CAGR during the forecast period, while North America held the largest market share in 2018.

 

Further key findings from the study suggest:

• Among the applications, chronic kidney disease segment held the largest IV iron drugs market share in 2018, due to increasing prevalence and geriatric population

• Ferric carboxymaltose is expected to maintain its dominance through the forecast period due to the increasing application in drug discovery, superior performance and reduced cost

• Asia Pacific is projected to exhibit the fastest growth during the forecast period, which can be attributed to the increasing prevalence of chronic diseases in the region, improving healthcare infrastructure, and rising per capita healthcare expenditure

• Key players operating in the intravenous iron drugs market include Allergan, Inc.,AMAG Pharmaceuticals. Inc.,Daiichi Sankyo Company, Ltd., Sanofi, Fresenius Medical Care AG & Co., Vifor Pharma Management Ltd., Pharmacosmos A/S, Shield Therapeutics Plc, and American Regent. Inc.

 

The “Intravenous Iron Drugs Market Size, Share & Trends Analysis Report” is available now at  https://www.radiantinsights.com/research/intravenous-iron-drugs-market

 

Table of Contents

 

Chapter 1 Methodology and Scope

1.1 Market segmentation & scope

1.2 Market definition

1.3 Information procurement

1.4 Purchased database

1.5 GVR's internal database

1.6 Secondary sources & third party perspectives

1.7 Primary research

1.8 Information analysis

1.9 Data analysis models

1.10 Market formulation & data visualization

1.11 Data validation & publishing

 

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

 

Chapter 3 Intravenous Iron Drugs Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Ancillary Market Outlook

3.2 Penetration and Growth Prospect Mapping

3.3 Regulatory Framework

3.4 Market Dynamics

3.4.1 Market driver analysis

3.4.2 Market restraint analysis

3.4.3 Industry challenges

3.4.4 Industry analysis - Porter's

3.4.4.1 Supplier Power

3.4.4.2 Buyer Power

3.4.4.3 Substitution Threat

3.4.4.4 Threat from new entrants

3.4.4.5 Competitive Rivalry

3.4.5 PESTEL Analysis

3.4.5.1 Political Landscape

3.4.5.2 Environmental Landscape

3.4.5.3 Social landscape

3.4.5.4 Technology landscape

3.4.5.5 Legal Landscape

3.4.6 Major deals and strategic alliances analysis

3.4.6.1 Joint ventures

3.4.6.2 Mergers and acquisitions

3.4.6.3 Licensing and partnership

3.4.6.4 Technology collaborations

3.4.6.5 Strategic Divestments

3.4.7 Market entry strategies

 

To read more reports of this category, Visit our blog: https://healthandpharamceuticalri.blogspot.com

 

Chapter 4 Intravenous Iron Drugs Market - Competitive Analysis

4.1 Recent Developments & Impact Analysis, by Key Market Participants

4.2 Company Categorization

4.3 Vendor Landscape

4.3.1 List of key distributors and channel partners

4.3.2 Key customers

4.3.3 Key company market share analysis, 2018

4.4 Public Companies

4.4.1 Company market position analysis

4.4.2 Regional network map

4.4.3 Company market share, by region

4.5 Private Companies

4.5.1 List of key emerging companies

4.5.2 Company market position analysis

 

Chapter 5 Intravenous Iron Drugs Market: Product Estimates and Trend Analysis

5.1 Definition & Scope

5.2 Product Market Share Analysis, 2018 & 2026

5.3 Segment Dashboard

5.4 Global Intravenous Iron Drugs Market, by Product, 2015 to 2026

5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026

5.5.1 Iron Sucrose Market

5.5.1.1 Iron Sucrose Market, 2015 to 2026 (USD Million)

5.5.2 Iron Dextran Market

5.5.2.1 Iron Dextran Market, 2015 to 2026 USD Million)

5.5.3 Ferric Carboxymaltose Market

5.5.3.1 Ferric Carboxymaltose Market, 2015 to 2026 (USD Million)

5.5.4 Others Market

5.5.4.1 Others Market, 2015 to 2026 (USD Million)

Like Reblog Comment
text 2020-07-24 14:05
Gynecology Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2027

Gynecology Drugs Market is estimated to value over USD 5 billion by 2027 end and register a CAGR of 5.3% from the forecast period 2020-2027.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecast By Therapeutics, by Indication, by Distribution Channel and by Region and Gynecology Drugs Market size.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in depth SWOT analysis of the market trends alongside the regional proliferation of this business vertical.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3479&page=requestsample
                 

Market Segmentation:

This Market is divided By Therapeutics, by Indication, by Distribution Channel and by Region.

Regionally, the worldwide Gynecology Drugs Market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.


Key Market Players:

Major market players enclosed within this market are

  • Hoffmann-La Roche Ltd.
  • Sanofi
  • Amgen Inc.
  • GlaxoSmithKline plc
  • AstraZeneca
  • Pfizer, Inc.
  • Lupin Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Bayer AG
  • Allergan Plc
  • Merck & Co.

(Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3479&page=askfordiscount


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points touching market growth

Competitive Landscape:

  • Tier 1 players- well-established companies in the market accounting a major market share  
  • Tier 2 players 
  • Rapidly growing players
  • New Entrants

Objectives of the Study:

  • To offer with an complete analysis on the Gynecology Drugs Market By Therapeutics, by Indication, by Distribution Channel and by Region
  • To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To measure and forecast micro-markets and also the overall market
  • To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions


Browse Corresponding Healthcare Market Research Reports & Consulting

  • Urinalysis Market is forecasted to value over USD 4.57 billion by 2027 end and register a CAGR of 7.5% from the forecast period 2020-2027. FutureWise Market Research has illustrated a report that provides an in-depth anatomy of the market trends affecting its growth.
  • Trocars Market is forecasted to value over USD 970 million by 2027 end and register a CAGR of 6.4% from the forecast period 2020-2027. FutureWise Market Research has illustrated a report that provides an in-depth anatomy of the market trends affecting its growth.

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

About FutureWise Research:

We specialize in high-growth niche markets, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person:  Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

Like Reblog Comment
text 2020-07-23 14:33
Sleeping Pills (Prescription Drugs) Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2027

Sleeping Pills (Prescription Drugs) Market is estimated to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecast By Type, By Application, By Region and Sleeping Pills (Prescription Drugs) Market size.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in depth SWOT analysis of the market trends alongside the regional proliferation of this business vertical.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=5527&page=requestsample
                 

Market Segmentation:

This Market is divided By Type, By Application and By Region.

Regionally, the worldwide Sleeping Pills (Prescription Drugs) Market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.


Key Market Players:

Major market players enclosed within this market are

  • SANOFI    
    • Abbott Laboratories    
    • TAKEDA PHARMACEUTICAL    
    • APOTEX  
    • AUROBINDO PHARMA
    • ACTELLON PHARMACEUTICALS
    • ALLEGIANT HEALTH
    • Cayman Chemical
    • Ambitropin
    • Hayao

(Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=5527&page=askfordiscount


FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points touching market growth

Competitive Landscape:

  • Tier 1 players- well-established companies in the market accounting a major market share  
  • Tier 2 players 
  • Rapidly growing players
  • New Entrants

Objectives of the Study:

  • To offer with an complete analysis on the Sleeping Pills (Prescription Drugs) Market By Type, By Application and By Region
  • To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To measure and forecast micro-markets and also the overall market
  • To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions


Browse Corresponding Healthcare Market Research Reports & Consulting

  • Neuropathic Pain Management Market neuropathic pain is a chronic pain condition caused owing to infection, trauma and other such dysfunctional systems in the nerves. Primary neuropathic pain syndromes include postherpetic neuralgia, painful neuropathy, painful traumatic mononeuropathy, central pain syndromes, complex regional pain syndrome and postsurgical pain syndromes. 
  • Next Generation IV Infusion Pumps Market advancements in the administration of intravenous medication, rising insistence for IV pumps from physicians, nurse anaesthetists and anaesthesiologist, soaring acceptance of smart pumps are some of the key factors responsible for the growth of the market. Furthermore, the emergence of reduction systems with less dosage errors shall bolster the next-generation IV infusion pumps market growth.

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

About FutureWise Research:

We specialize in high-growth niche markets, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person:  Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

More posts
Your Dashboard view:
Need help?